A detailed history of Resurgent Financial Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Resurgent Financial Advisors LLC holds 880 shares of VRTX stock, worth $394,248. This represents 0.24% of its overall portfolio holdings.

Number of Shares
880
Previous 899 2.11%
Holding current value
$394,248
Previous $421,000 2.85%
% of portfolio
0.24%
Previous 0.26%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$460.0 - $505.78 $8,740 - $9,609
-19 Reduced 2.11%
880 $409,000
Q2 2024

Aug 14, 2024

SELL
$392.81 - $485.53 $39,281 - $48,553
-100 Reduced 10.01%
899 $421,000
Q1 2024

May 10, 2024

BUY
$407.69 - $446.08 $77,053 - $84,309
189 Added 23.33%
999 $417,000
Q4 2023

Feb 09, 2024

BUY
$343.0 - $410.68 $196,882 - $235,730
574 Added 243.22%
810 $329,000
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $5,749 - $6,161
17 Added 7.76%
236 $82,000
Q2 2023

Aug 14, 2023

SELL
$314.42 - $351.91 $2,200 - $2,463
-7 Reduced 3.1%
219 $77,000
Q1 2023

May 15, 2023

SELL
$283.23 - $323.1 $133,967 - $152,826
-473 Reduced 67.67%
226 $71,000
Q4 2022

Feb 14, 2023

SELL
$285.76 - $321.48 $181,171 - $203,818
-634 Reduced 47.56%
699 $201,000
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $19,715 - $21,998
72 Added 5.71%
1,333 $386,000
Q2 2022

Aug 15, 2022

SELL
$234.96 - $292.55 $17,856 - $22,233
-76 Reduced 5.68%
1,261 $355,000
Q1 2022

May 16, 2022

BUY
$221.42 - $260.97 $296,038 - $348,916
1,337 New
1,337 $349,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $115B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Resurgent Financial Advisors LLC Portfolio

Follow Resurgent Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resurgent Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resurgent Financial Advisors LLC with notifications on news.